First-in-class therapies for diseases caused by aging
Fountain Therapeutics is a clinical-stage biopharmaceutical company discovering and developing first-in-class therapies for diseases and conditions caused by aging. The company's AI-driven biology platform identifies targets connecting aging biology to chronic degenerative diseases, with lead programs in skin atrophy and sarcopenia. Fountain is backed by Khosla Ventures, Lilly, Nan Fung Life Sciences, and Alexandria Venture Investments.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
